IF GvHD is back on then this would be massive for share price especially if it includes a FDA pathway, considering another company had a valuation of $1 billion placed by analysts just on an anticipated FDA approved GvHD stem cell treatment...obviously CYP only receives milestone payments and royalties but still food for thought
IF GvHD is back on then this would be massive for share price...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.29M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.0¢ | 27.5¢ | $36.56K | 130.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3702 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 17696 | 1 |
View Market Depth
| Last trade - 15.03pm 26/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |